Skip to content

J&J sales, earnings notch up

April 18, 2017

Johnson & Johnson, which is in the process of completing its $30 billion acquisition of Swiss biotech Actelion, reported on Tuesday a 1.6 percent rise in first-quarter sales.

The diversified healthcare company’s sales rose to $17.77 billion in the first quarter from $17.48 billion a year earlier.

J&J’s net earnings in the quarter were $4.42 billion, or $1.61 per share. The company reported net earnings of $4.46 billion, or $1.59 per share, a year ago.


From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: